Drugs

Indegene, a pioneer in digital healthcare solutions, has unveiled a new center in Hyderabad to bolster its global service capabilities, meeting the expanding demands of its business. Amidst mounting expectations for innovation and adaptation within the pharmaceutical sector, this freshly […]

Tata Elxsi, renowned worldwide for its expertise in design and technology services, has joined forces with DENSO Robotics Europe and AAtek to unveil a newly established ‘Robotics and Automation Innovation Center’ at their Frankfurt location. This innovative facility is poised

India’s leading cancer care provider, HealthCare Global Enterprises (HCG), has unveiled a research initiative in partnership with the innovative startup, Trucan Diagnostics Pvt Ltd, known for its cutting-edge cancer diagnostics. The goal of this collaboration is to authenticate a range

Lupin Limited, a key player in the global pharmaceutical landscape, has declared that it obtained the green light from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA). This milestone covers the production of

India’s medical tourism industry is rapidly expanding, establishing the nation as a premier global hub for cost-effective and superior healthcare solutions. The country’s reputation is bolstered by healthcare facilities like PSRI Hospital, which excel in patient-focused, clinical care, affirming India’s

The Telangana government has proudly reported remarkable strides in the life sciences domain, amassing investments exceeding Rs. 36,000 crore across more than 140 projects within the past year. These investments are projected to generate 51,000 direct employment opportunities and approximately

Anixa Biosciences, Inc. (Anixa), a biotech firm dedicated to cancer treatment and prevention, revealed its initiation of patient treatment in the third cohort of its ongoing Phase 1 clinical trial. This trial explores their innovative chimeric antigen receptor-T cell (CAR-T)

Scientists at the National Institutes of Health (NIH) have engineered an innovative artificial intelligence (AI) system aimed at optimizing the matching of prospective trial participants with appropriate clinical research studies listed on ClinicalTrials.gov. A paper in Nature Communications highlights the

TAHO Pharmaceuticals Ltd. has begun administering doses to participants in its phase III trial in the US for its leading product, TAH3311, a pioneering antithrombotic oral dissolving film (ODF). In July 2023, their proposal for a 505(b)(2) NDA submission, which

Cytokinetics, a specialty biopharmaceutical company focusing on cardiovascular diseases in advanced stages, has joined forces with Bayer through an exclusive collaboration and licensing arrangement. This partnership aims to advance the development and marketing of aficamten for patients in Japan suffering